Immunoaffinity LC-MS/MS or hybrid LC-MS/MS is an approach that has been gaining a lot of traction in the past several years.  The technique allows the quantitation of low-level analytes (proteins or peptides in many cases) in biological matrices with exquisite selectivity and sensitivity. Many pharmaceutical companies are trying to expand…

In the complex and dynamic bioanalytical landscape of antibody-drug conjugate (ADC) services, where often time is critical and every research dollar counts, hybrid technology is quickly emerging as a game-changer. Hybrid offers a spectrum of advantages that redefine traditional approaches to bioanalytical ADC drug development. At the forefront of these…

If you are part of the Biotech/Pharma community, you may be familiar with the (J.P. Morgan) JPM Healthcare Conference that takes place annually in January and typically in San Francisco. This was the 42nd Annual JPM Healthcare Conference and it is the world’s largest healthcare symposium. This year the mood…

To kick off the first episode of “The Weekly Bioanalysis” in 2024, Dom and John unveil some fun new things happening at KCAS Bio, by talking about the parallel evolution of the bioanalytical industry and KCAS Bio. Our hosts go way back – almost to “square one” (discussing…

In the fast-paced and highly competitive landscape of contract research organizations (CROs) — where data serves as the cornerstone for all operations — robust data security practices are paramount. CROs play a pivotal role in the biopharma industry. They serve as trusted partners for conducting crucial studies and managing sensitive…

Immunoassays are bioanalytical methods that generally use antibodies to detect and quantify specific analytes, often proteins, in biological samples. The process involves the capture of a target protein by an immobilized antibody, followed by its detection with another antibody conjugated either to enzymes, such as phosphatase alkaline or horseradish peroxidase…

The American Society of Gene & Cell Therapy (ASGCT) annual meeting is the premier gathering for scientists, physicians, industry leaders, and patient advocates working at the forefront of gene and cell therapy. This year’s meeting, taking place in Baltimore, MD from May 7th to 11th, 2024, promises to be an…

The World Vaccine Congress, taking place April 1-4 in Washington D.C., is shaping up to be a landmark event for the vaccine community. This four-day conference will bring together over 450 speakers and 250 exhibitors from across the globe to discuss the latest advancements in vaccine science, development, and manufacturing.

The AD/PD™ 2024: Alzheimer’s & Parkinson’s Diseases Conference is set to take place in Lisbon, Portugal, from March 5th to 9th, 2024. This prestigious event, dubbed the “main event of the year in the field of neurodegenerative diseases,” promises to gather leading experts from around the world to share the…

Mark your calendars, life science innovators! The AAPS National Biotechnology Conference (NBC) is gearing up for another groundbreaking year, and KCAS Bio is excited to be at the forefront of the action. From May 13th to 16th, 2024, San Francisco will transform into a hub of cutting-edge research, industry breakthroughs,…

The Workshops on Recent Issues in Bioanalysis (WRIB) is an annual conference that brings together scientists from around the world to discuss the latest advances in bioanalytical science. The conference features presentations from industry leaders and regulators, as well as interactive sessions where attendees can ask questions and learn from…

The Boston Society Gene & Cell Therapy Conference, renowned for its focus on translating groundbreaking scientific ideas into practical industrial applications, returns for another enriching gathering. This year’s event promises to be an invaluable platform for researchers, engineers, and industry leaders to connect, share knowledge, and shape the future of…